1. Head-to-pelvis CT imaging after sudden cardiac arrest: Current status and future directions.
- Author
-
Branch KR, Nguyen ML, Kudenchuk PJ, and Johnson NJ
- Subjects
- Humans, Retrospective Studies, Death, Sudden, Cardiac etiology, Death, Sudden, Cardiac prevention & control, Tomography, X-Ray Computed methods, Abdomen, Pelvis, Heart Arrest therapy, Cardiopulmonary Resuscitation adverse effects
- Abstract
Causes for sudden circulatory arrest (SCA) can vary widely making early treatment and triage decisions challenging. Additionally, cardiopulmonary resuscitation (CPR), while a life-saving link in the chain of survival, can be associated with traumatic injuries. Computed tomography (CT) can identify many causes of SCA as well as its sequelae. However, the diagnostic and therapeutic impact of CT in survivors of SCA has not been reviewed to date. This general review outlines the rationale and potential applications of focused head, chest, and abdomen/pelvis CT as well as comprehensive head-to-pelvis CT imaging after SCA. CT has a diagnostic yield approaching 30% to identify causes of SCA while the addition of ECG-gated chest CT provides further information about coronary anatomy and cardiac function. Risks of CT include radiation exposure, contrast-induced kidney injury, and incidental findings. This review's findings suggest that routine head-to-pelvis CT can yield clinically actional findings with the potential to improve clinical outcome after SCA that merits further investigation., Competing Interests: Declaration of Competing Interest The authors declare the following financial interests/personal relationships which may be considered as potential competing interests: ‘Kelley Branch reports a relationship with Bayer AG that includes: consulting or advisory, funding grants, and travel reimbursement. Kelley Branch reports a relationship with Sanofi that includes: funding grants. Kelley Branch reports a relationship with Eli Lilly and Company that includes: funding grants. Kelley Branch reports a relationship with Kestra Medical Technologies Inc that includes: funding grants. Kelley Branch reports a relationship with Janssen Pharmaceuticals Inc that includes: consulting or advisory.’., (Copyright © 2023. Published by Elsevier B.V.)
- Published
- 2023
- Full Text
- View/download PDF